JPH05310797A - Method for separating ovomucoid - Google Patents

Method for separating ovomucoid

Info

Publication number
JPH05310797A
JPH05310797A JP14815692A JP14815692A JPH05310797A JP H05310797 A JPH05310797 A JP H05310797A JP 14815692 A JP14815692 A JP 14815692A JP 14815692 A JP14815692 A JP 14815692A JP H05310797 A JPH05310797 A JP H05310797A
Authority
JP
Japan
Prior art keywords
ovomucoid
trichloroacetic acid
molecular weight
separating
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14815692A
Other languages
Japanese (ja)
Inventor
Yoshihisa Fujii
義久 藤井
Yoshihiro Akazawa
佳宏 赤澤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nok Corp
Original Assignee
Nok Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nok Corp filed Critical Nok Corp
Priority to JP14815692A priority Critical patent/JPH05310797A/en
Publication of JPH05310797A publication Critical patent/JPH05310797A/en
Pending legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

PURPOSE:To separate ovomucoid without requiring many hours in operation and damaging physiological activity of ovomucoid in separating ovomucoid from egg-white protein. CONSTITUTION:Egg-white protein is dissolved in 5-10wt.% aqueous solution of trichloroacetic acid, the supernatant liquid is filtered by an ultrafilter having >=50,000 fractioned molecular weight, trichloroacetic acid is removed by dialysis method and the solution is concentrated with an ultrafilter <=50,000 fractioned molecular weight to separate ovomucoid.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、オボムコイドの分離方
法に関する。更に詳しくは、卵白たん白質からのオボム
コイドの分離方法に関する。
FIELD OF THE INVENTION The present invention relates to a method for separating ovomucoid. More specifically, it relates to a method for separating ovomucoid from egg white protein.

【0002】[0002]

【従来の技術】卵白中には約40種類のたん白質が含まれ
ており、その内工業的に分離が容易で、有用な生理活性
を有するリゾチームが利用されているが、リゾチームを
分離した後の卵白中にも、有用な生理活性を有するたん
白質であるオボムコイドが11%程度存在している。
2. Description of the Related Art Egg white contains about 40 kinds of proteins, and lysozyme having industrially easy separation and useful physiological activity is used. Ovomucoid, which is a protein having useful physiological activity, is present in the egg white of about 11%.

【0003】オボムコイドは、分子量が28000、等電点
が3.9〜4.5の糖たん白質であって、卵白中に存在する耐
熱性のトリプシンインヒビタであり、キモトリプシンに
対しても作用し、失活させる。また、アンヒドロトリプ
シン(活性中心のセリンがデヒドロアラニンで置換され
たもの)、トシルリシルクロロメチルケトン処理したト
リプシン、トシルフェニルアラニルクロロメチルケトン
処理したキモトリプシンなどの失活した酵素とも複合体
を形成させる。
Ovomucoid is a glycoprotein having a molecular weight of 28,000 and an isoelectric point of 3.9 to 4.5, which is a heat-resistant trypsin inhibitor present in egg white and also acts on chymotrypsin to inactivate it. It also forms a complex with inactivated enzymes such as anhydrotrypsin (active center serine substituted with dehydroalanine), tosyllysyl chloromethyl ketone treated trypsin, and tosyl phenylalanyl chloromethyl ketone treated chymotrypsin. Let

【0004】このような生理活性を有するオボムコイド
については、従来工業的に大量廉価に分離する技術が確
立されてはおらず、以下の如き実験室的レベルの分離法
にとどまっている。
With respect to the ovomucoid having such a physiological activity, a technique for industrially mass-separating the ovomucoid at a low cost has not been established in the past, and only the following laboratory-level separation method is available.

【0005】その代表的な分離法は、沈殿法とイオン交
換クロマトグラフィー法である。後者の方法は、カルボ
キシルメチルセルロースまたはジエチルアミノエチルセ
ルロースを担体としており、オボムコイドの分離状態や
回収率は良いものの、1回の操作にカルボキシメチルセ
ルロースの場合で約25時間、ジエチルアミノエチルセル
ロースの場合で約18時間を必要とするため、非効率的で
ある。
Typical separation methods are precipitation method and ion exchange chromatography method. The latter method uses carboxymethylcellulose or diethylaminoethylcellulose as a carrier, and although the ovomucoid separation and recovery rate are good, it takes about 25 hours for carboxymethylcellulose and about 18 hours for diethylaminoethylcellulose per operation. Therefore, it is inefficient.

【0006】一方、前者の方法も、一度に大量処理でき
るという利点はみられるものの、以下に述べるようにオ
ボムコイドを完全に分離する迄に長い工程(1)〜(6)を必
要とし、各工程に時間を要するばかりではなく、硫酸ア
ンモニウムを大量に使用するためその廃棄処理にコスト
がかかり、またオボムコイドを100℃で5分間熱処理する
ため、その生理活性が損なわれるおそれがある。 (1)リゾチーム、アビジン除去済みの卵白たん白質溶液
(pH7.0)に等量の硫酸アンモニウムを加え、遠心機で上
層を回収する。 (2)上層液中に結晶化が始まる迄、0.5M硫酸をゆっくり
と添加する。その後、更に0.5M硫酸を添加してpHを4.6
に調整し、一夜結晶化させる。 (3)遠心機で回収した上層液100ml当り8gの硫酸アンモニ
ウムを添加する。 (4)遠心機で回収した上層液を硫酸アンモニウムで飽和
する。 (5)遠心機で上層を捨て、沈殿を回収し、沈殿を水に溶
かし、100℃で5分間熱処理する。 (6)遠心機で上層を回収し、上層を0℃の温度条件下で、
65%エタノールで透析し、オボムコイドを回収する。
On the other hand, the former method also has the advantage that a large amount of treatment can be carried out at one time, but as described below, long steps (1) to (6) are required until the ovomucoid is completely separated. Not only does it take time, but the disposal of the ammonium sulphate is expensive because of the large amount of ammonium sulfate used, and the ovomucoid is heat-treated at 100 ° C. for 5 minutes, which may impair its physiological activity. (1) Egg protein protein solution with lysozyme and avidin removed
Add an equal amount of ammonium sulfate to (pH 7.0) and collect the upper layer with a centrifuge. (2) Slowly add 0.5 M sulfuric acid until crystallization starts in the upper layer liquid. Then, add 0.5 M sulfuric acid to adjust the pH to 4.6.
Adjust to and crystallize overnight. (3) Add 8 g of ammonium sulfate per 100 ml of the upper layer liquid collected by the centrifuge. (4) Saturate the upper layer liquid collected by the centrifuge with ammonium sulfate. (5) Discard the upper layer with a centrifuge, collect the precipitate, dissolve the precipitate in water, and heat at 100 ° C. for 5 minutes. (6) The upper layer is collected with a centrifuge, and the upper layer is heated at 0 ° C under a temperature condition of
Dialyze with 65% ethanol to collect ovomucoid.

【0007】[0007]

【発明が解決しようとする課題】本発明の目的は、卵白
たん白質からオボムコイドを分離するに際し、操作に長
時間を要せず、しかもオボムコイドの生理活性を損なわ
ない分離方法を提供することにある。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a method for separating ovomucoid from egg white protein that does not require a long time for operation and does not impair the physiological activity of ovomucoid. ..

【0008】[0008]

【課題を解決するための手段】かかる本発明の目的は、
濃度5〜10重量%のトリクロロ酢酸水溶液中に卵白たん白
質を溶解させ、その上澄液を分画分子量50000以上の限
外ロ過膜でロ過した後、透析法でトリクロロ酢酸を除去
し、その溶液について分画分子量50000以下の限外ロ過
膜で濃縮するオボムコイドの分離方法によって達成され
る。
The object of the present invention is as follows.
Egg protein was dissolved in an aqueous solution of trichloroacetic acid having a concentration of 5 to 10% by weight, and the supernatant was filtered through an ultrafiltration membrane having a molecular weight cutoff of 50,000 or more, and then trichloroacetic acid was removed by dialysis. It is achieved by a method of separating ovomucoid which concentrates on the solution with an ultrafiltration membrane having a molecular weight cut-off of 50,000 or less.

【0009】卵白たん白質としては、リゾチーム、アビ
ジンなどを除去する前のものあるいはこれらを除去した
後のもののいずれをも用いることができる。卵白たん白
質は、それを約5〜15倍の純水で希釈し、その水溶液に
例えば濃度50重量%のトリクロロ酢酸水溶液が加えら
れ、上記希釈水によってトリクロロ酢酸水溶液としての
濃度が5〜10重量%となるように調整される。トリクロロ
酢酸は強酸であるため、濃度が高すぎると、オボムコイ
ドを含めたすべてのたん白質を変性させてしまうので、
その水溶液としての最高濃度は10重量%に限定される。
一方、これ以下の水溶液濃度では、所望の効果が得られ
ない。
As the egg protein, any of those before removal of lysozyme, avidin and the like or those after removal thereof can be used. Egg protein is diluted with about 5 to 15 times pure water, and an aqueous solution of trichloroacetic acid having a concentration of 50% by weight, for example, is added to the aqueous solution. Adjusted to be%. Since trichloroacetic acid is a strong acid, if its concentration is too high, it will denature all proteins including ovomucoid.
Its maximum concentration as an aqueous solution is limited to 10% by weight.
On the other hand, if the concentration of the aqueous solution is less than this, the desired effect cannot be obtained.

【0010】また、卵白たん白質とトリクロロ酢酸との
量的関係については、混合液のpHが好ましくは0.9〜2.0
の範囲になるように選択される。これ以下のpHでは、オ
ボムコイドが変性してしまい、一方これ以上のpHにする
と、オボムコイド以外のすべてのたん白質を沈殿させる
ことができなくなる。
Regarding the quantitative relationship between egg protein and trichloroacetic acid, the pH of the mixed solution is preferably 0.9 to 2.0.
Is selected to be in the range. At a pH below this, the ovomucoid will be denatured, while at a pH above this it will not be possible to precipitate any protein other than ovomucoid.

【0011】このようにして、濃度5〜10重量%のトリク
ロロ酢酸水溶液中に卵白たん白質を溶解させた混合液
を、約1時間程度静置した後、その上澄液を分画分子量
50000以上、好ましくは100000〜500000の限外ロ過膜で
ロ過して、他のたん白質成分などの沈殿成分を除去す
る。ここ迄の所要時間は、約3時間程度である。
In this manner, the mixed solution prepared by dissolving the egg protein in the aqueous solution of trichloroacetic acid having a concentration of 5 to 10% by weight is allowed to stand for about 1 hour, and then the supernatant is subjected to a molecular weight cut-off.
Precipitated components such as other protein components are removed by filtration with an ultrafiltration membrane of 50,000 or more, preferably 100,000 to 500000. It takes about 3 hours to reach here.

【0012】この限外ロ過によって得られた、オボムコ
イドを主成分とする溶液から、透析法によってトリクロ
ロ酢酸を除去した後、その溶液について分画分子量5000
0以下、好ましくは50000〜20000の限外ロ過膜を用いて
の濃縮が行われ、膜に付着したゲル状のたん白質を減圧
乾燥して、白色粉末としてのオボムコイドを得る。
From the solution containing ovomucoid as the main component obtained by this ultrafiltration, trichloroacetic acid was removed by a dialysis method, and then the molecular weight cutoff of the solution was 5000
Concentration is performed using an ultrafiltration membrane of 0 or less, preferably 50,000 to 20,000, and the gel-like protein attached to the membrane is dried under reduced pressure to obtain ovomucoid as a white powder.

【0013】[0013]

【発明の効果】卵白たん白質からオボムコイドを分離す
るに際し、トリクロロ酢酸を用いて他のたん白質などを
効率良く除去することにより、従来法よりは著しく短時
間でしかも生理活性を損なわせないでオボムコイドを得
ることができる工業的な方法が確立された。
[Effects of the Invention] When ovomucoid is separated from egg protein, other proteins etc. are efficiently removed by using trichloroacetic acid. An industrial method was established by which the

【0014】[0014]

【実施例】次に、実施例について本発明を説明する。EXAMPLES The present invention will now be described with reference to examples.

【0015】実施例 卵白たん白質80gを純水で約10倍に希釈した水溶液に、5
0重量%トリクロロ酢酸水溶液100mlを加えた(トリクロロ
酢酸水溶液濃度約6重量%)。この混合液(pH1.2)を容量2
Lのビーカーに入れ、約1時間静置した後、その上澄液
を分画分子量約200000の限外ロ過膜を用い、クロスフロ
ー方式でロ過して、沈殿成分を除去した。約850mlのロ
液については、分画分子量約10000の透析膜を用いて約1
0時間透析し、トリクロロ酢酸を除去した。
Example 1 80 g of egg white protein was diluted with pure water about 10 times, and
100 ml of 0 wt% trichloroacetic acid aqueous solution was added (concentration of trichloroacetic acid aqueous solution was about 6 wt%). Volume of this mixture (pH 1.2) is 2
After being placed in a L beaker and allowed to stand for about 1 hour, the supernatant was filtered by a cross-flow method using an ultrafiltration membrane having a cut-off molecular weight of about 200,000 to remove precipitated components. About 850 ml of the filtrate, about 1 using a dialysis membrane with a molecular weight cutoff of about 10,000.
It was dialyzed for 0 hour to remove trichloroacetic acid.

【0016】以上の各工程を経て得た約800mlの溶液
を、分画分子量約40000の限外ロ過膜を用いて、クロス
フロー方式で濃縮し、ロ過膜表面に付着したゲル状のた
ん白質を膜に付着させたまま40℃で減圧乾燥し、約0.3g
のオボムコイドを白色の粉末として得た。それの確認
は、HPLC法(電気泳動法)によって行われた。
About 800 ml of the solution obtained through the above steps was concentrated by a cross-flow method using an ultrafiltration membrane having a molecular weight cut off of about 40,000, and the gel-like protein attached to the surface of the filtration membrane was concentrated. About 0.3g
Of ovomucoid was obtained as a white powder. The confirmation was performed by the HPLC method (electrophoresis method).

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 濃度5〜10重量%のトリクロロ酢酸水溶液
中に卵白たん白質を溶解させ、その上澄液を分画分子量
50000以上の限外ロ過膜でロ過した後、透析法でトリク
ロロ酢酸を除去し、その溶液について分画分子量50000
以下の限外ロ過膜で濃縮することを特徴とするオボムコ
イドの分離方法。
1. An egg protein is dissolved in an aqueous solution of trichloroacetic acid having a concentration of 5 to 10% by weight, and the supernatant thereof is fractionated to have a molecular weight.
After filtration with an ultrafiltration membrane of 50,000 or more, trichloroacetic acid was removed by a dialysis method, and the molecular weight cutoff of the solution was 50,000.
The following method for separating ovomucoid, which comprises concentrating with an ultrafiltration membrane.
JP14815692A 1992-05-14 1992-05-14 Method for separating ovomucoid Pending JPH05310797A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14815692A JPH05310797A (en) 1992-05-14 1992-05-14 Method for separating ovomucoid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14815692A JPH05310797A (en) 1992-05-14 1992-05-14 Method for separating ovomucoid

Publications (1)

Publication Number Publication Date
JPH05310797A true JPH05310797A (en) 1993-11-22

Family

ID=15446515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14815692A Pending JPH05310797A (en) 1992-05-14 1992-05-14 Method for separating ovomucoid

Country Status (1)

Country Link
JP (1) JPH05310797A (en)

Similar Documents

Publication Publication Date Title
JP3676370B2 (en) filtration
US4322275A (en) Fractionation of protein mixtures
US4351710A (en) Fractionation of protein mixtures
US4473494A (en) Preparation of stroma-free, non-heme protein-free hemoglobin
JP3094167B2 (en) Purification method of immune serum globulin
Pope Disaggregation of proteins by enzymes
LU501670B1 (en) A Method for as1-Casein Separation
JPS584728A (en) Purification of alpha-1 antitrypsin
EP3362464B1 (en) Methods for extracting proteins from blood plasma
US4764279A (en) Process for preparing the principal proteins of hemolyzed blood in the non-denatured form
EP1037923B2 (en) Method for preparing by filtration a virally secure factor viii solution
EP0512883A1 (en) Concentrate of blood coagulation factor XI with high specific activity, appropriate for therapeutic use and its process of preparation
CA1054052A (en) Simplified method for preparation of high yield, high purity factor viii concentrate
JPH03180182A (en) Purification of phage dna
JPH05310797A (en) Method for separating ovomucoid
EP0067293B1 (en) Method for isolating alpha-1-antitrypsin
JPH05271295A (en) Production of composition with high content of kappa-caseinglycomacropeptide
JP2008534687A (en) High separation method and precipitation reagent for isolating proteins from proteinaceous substances
JP3225081B2 (en) Method for producing a composition having a high content of kappa-casein glycomacropeptide
Melling et al. The influence of ph value and ionic strength on the ultrafiltration characteristics of a penicillinase produced by Escherichia coli Strain W3310
JPS6119454A (en) Preparation of protein hydrolyzate
JPH07173190A (en) Method for fractionating plasma protein
US3477911A (en) Method of production of urokinase
JPH02111728A (en) Production of albumin preparation
JPH01213300A (en) Recovery of protein from erythrocyte